𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review

✍ Scribed by Vanita R. Aroda; Robert Ratner

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
197 KB
Volume
27
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gut and the Induction of Immune Toleranc
Gut and the Induction of Immune Tolerance in Type 1 Diabetes
✍ Outi Vaarala 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The origin of b-cell speci®c autoimmunity is not known in Type 1 diabetes. Several studies of this disease in animal models indicate that the manifestation of autoimmune diabetes can be modi®ed by factors which in¯uence the gut immune system. Some indirect evidence from studies in patients with Type

Presence of a functional receptor for GL
Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor
✍ Bernardo Nuche-Berenguer; Sergio Portal-Núñez; Paola Moreno; Nieves González; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract Glucagon‐like peptide 1 (GLP‐1) controls glucose metabolism in extrapancreatic tissues through receptors other than the pancreatic cAMP‐linked GLP‐1 receptor; also, GLP‐1 induces an insulin‐ and PTH‐independent bone anabolic action in insulin‐resistant and type‐2 diabetic rats. Here we